Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -18.06% is 16% below its 5-year average of -15.51%, around the middle of its 5-year range (-53.59%–9.81%).
20.96% above its 12-month average of -22.85%.
Reported quarterly EBITDA margin; no daily interpolation. Q1 FY2026 (2026-06-30): -18.64%.
EBITDA MARGIN
-18.06%
EBITDA MARGIN AVG TTM
-22.85%
EBITDA MARGIN AVG 3Y
-23.72%
EBITDA MARGIN AVG 5Y
-15.51%
EBITDA MARGIN AVG 10Y
-10.79%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+20.96%
CURRENT VS 3Y AVG
+23.85%
CURRENT VS 5Y AVG
-16.46%
CURRENT VS 10Y AVG
-67.43%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Addentax Group Corp.
Market Cap
$3.51M
EBITDA Margin
-18.06%
TTM Avg
-22.85%
3Y Avg
-23.72%
5Y Avg
-15.51%
Market Cap
$3.31M
EBITDA Margin
-60.70%
TTM Avg
-63.88%
3Y Avg
-65.94%
5Y Avg
-81.03%
Market Cap
$3.78M
EBITDA Margin
-57.86%
TTM Avg
-28.63%
3Y Avg
-17.89%
5Y Avg
-9.88%
Market Cap
$3.09M
EBITDA Margin
-40.27%
TTM Avg
-27.61%
3Y Avg
-20.59%
5Y Avg
-10.26%
Market Cap
$2.93M
EBITDA Margin
-105.34%
TTM Avg
-42.86%
3Y Avg
-8.83%
5Y Avg
21.58%
Market Cap
$4.16M
EBITDA Margin
-30.36%
TTM Avg
-14.68%
3Y Avg
-5.76%
5Y Avg
-0.90%
Market Cap
$4.18M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.69M
EBITDA Margin
-161.83%
TTM Avg
-364.15%
3Y Avg
-746.27%
5Y Avg
-739.07%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Addentax Group Corp. (ATXG) | $3.51M | -18.06% | -22.85% | -23.72% | -15.51% |
| INLIF Limited (INLF)vs › | $3.54M | -29.83% | -9.74% | 2.51% | 4.46% |
| Iveda Solutions, Inc. (IVDA)vs › | $3.31M | -60.70% | -63.88% | -65.94% | -81.03% |
| Baiya International Group Inc. (BIYA)vs › | $3.78M | -57.86% | -28.63% | -17.89% | -9.88% |
| BioNexus Gene Lab Corp. (BGLC)vs › | $3.09M | -40.27% | -27.61% | -20.59% | -10.26% |
| Intelligent Group Limited (INTJ)vs › | $2.93M | -105.34% | -42.86% | -8.83% | 21.58% |
| Highway Holdings Limited (HIHO)vs › | $4.16M | -30.36% | -14.68% | -5.76% | -0.90% |
| Liberty Defense Holdings, Ltd. Common Shares (DETX)vs › | $4.18M | N/A | N/A | N/A | N/A |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.69M | -161.83% | -364.15% | -746.27% | -739.07% |
| Globavend Holdings Limited (GVH)vs › | $2.68M | 4.51% | 6.50% | 5.75% | 5.47% |
Gross Margin
12.3%
EBITDA Margin
-18.1%
Operating Margin
-23.2%
Net Margin
-21.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -18.64% |
| 2026-03-31 | -21.75% |
| 2025-12-31 | -2.00% |
| 2025-09-30 | -49.56% |
| 2025-06-30 | -22.30% |
| 2025-03-31 | -29.41% |
| 2024-12-31 | -33.77% |
| 2024-09-30 | -16.26% |
| 2024-06-30 | -53.59% |
| 2024-03-31 | 9.81% |
| 2023-12-31 | -28.64% |
| 2023-09-30 | -21.11% |
| 2023-06-30 | -21.56% |
| 2023-03-31 | -31.45% |
| 2022-12-31 | 0.02% |
| 2022-09-30 | 9.60% |
| 2022-06-30 | 3.44% |
| 2022-03-31 | -1.79% |
| 2021-12-31 | 0.59% |
| 2021-09-30 | 0.14% |
| 2021-06-30 | 2.58% |
| 2021-03-31 | 0.07% |
| 2020-12-31 | -8.31% |
| 2020-09-30 | -29.43% |
| 2020-06-30 | 3.58% |
| 2020-03-31 | 3.73% |
| 2019-12-31 | -5.40% |
| 2019-09-30 | -14.47% |
| 2019-06-30 | -14.71% |
| 2019-03-31 | -3.84% |
| 2018-12-31 | -20.33% |
| 2018-09-30 | 5.86% |
| 2018-06-30 | -5.24% |
| 2018-03-31 | -6.17% |
| 2017-12-31 | -1.27% |
| 2017-09-30 | 0.45% |
| 2017-06-30 | 0.07% |
| 2016-12-31 | 0.08% |
| 2016-09-30 | 0.33% |
| 2016-06-30 | -700.47% |
| 2015-12-31 | -1.96% |
| 2015-09-30 | -57.53% |
